Corline Biomedical AB (CLBIO) - Total Liabilities

Latest as of September 2025: Skr5.09 Million SEK ≈ $547.33K USD

Based on the latest financial reports, Corline Biomedical AB (CLBIO) has total liabilities worth Skr5.09 Million SEK (≈ $547.33K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Corline Biomedical AB cash conversion from operations to assess how effectively this company generates cash.

Corline Biomedical AB - Total Liabilities Trend (2012–2024)

This chart illustrates how Corline Biomedical AB's total liabilities have evolved over time, based on quarterly financial data. Check Corline Biomedical AB liquidity resilience to evaluate the company's liquid asset resilience ratio.

Corline Biomedical AB Competitors by Total Liabilities

The table below lists competitors of Corline Biomedical AB ranked by their total liabilities.

Company	Country	Total Liabilities
B&B Triplewall Containers Limited NSE:BBTCL	India	Rs2.84 Billion
Opnet Technologies Co Ltd TWO:8034	Taiwan	NT$137.78 Million
Entropy Neurodynamics Limited AU:ENP	Australia	AU$699.17K
3U Holding AG XETRA:UUU	Germany	€63.35 Million
Vate Technology Co Ltd TWO:5344	Taiwan	NT$103.01 Million
Orient Paper & Industries Limited NSE:ORIENTPPR	India	Rs6.60 Billion
Gigas Hosting S.A MC:GIGA	Spain	€121.27 Million
Johnson Matthey PLC LSE:JMAT	UK	GBX3.90 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Corline Biomedical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Corline Biomedical AB.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	1.14	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Corline Biomedical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Corline Biomedical AB (2012–2024)

The table below shows the annual total liabilities of Corline Biomedical AB from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr7.85 Million ≈ $844.57K	+15.60%
2023-12-31	Skr6.79 Million ≈ $730.60K	-5.63%
2022-12-31	Skr7.19 Million ≈ $774.19K	-23.69%
2021-12-31	Skr9.43 Million ≈ $1.01 Million	+50.83%
2020-12-31	Skr6.25 Million ≈ $672.60K	+40.99%
2019-12-31	Skr4.43 Million ≈ $477.06K	-44.26%
2018-12-31	Skr7.95 Million ≈ $855.87K	+44.57%
2017-12-31	Skr5.50 Million ≈ $592.00K	+117.52%
2016-12-31	Skr2.53 Million ≈ $272.16K	-32.46%
2015-12-31	Skr3.74 Million ≈ $402.98K	-66.83%
2014-12-31	Skr11.29 Million ≈ $1.21 Million	+95.96%
2013-12-31	Skr5.76 Million ≈ $619.91K	-48.05%
2012-12-31	Skr11.09 Million ≈ $1.19 Million	--

About Corline Biomedical AB

ST:CLBIO Sweden Biotechnology

Market Cap

$42.30 Million

Skr393.08 Million SEK

Market Cap Rank

#22495 Global

#416 in Sweden

Share Price

Skr16.05

Change (1 day)

-0.62%

52-Week Range

Skr9.66 - Skr21.20

All Time High

Skr28.20